Similar articles for PMID: 24526195

Year	Number of Results
1977	1
1978	1
1981	1
1982	1
1983	1
1984	1
1987	2
1988	1
1989	1
1990	2
1991	1
1992	4
1993	2
1994	2
1995	2
1997	4
1998	1
1999	5
2000	3
2001	3
2002	3
2003	5
2005	8
2006	3
2007	4
2008	5
2009	2
2010	3
2011	3
2012	6
2014	3
2015	5
2016	1
2017	3
2018	5
2019	2
2020	4
2021	2
2022	1
2023	2
2024	0

1

Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to Graves' disease: considerations with respect to treatment.

Mathot V, Oosterwerff E, van Pampus MG, Riezebos R. Mathot V, et al. BMJ Case Rep. 2014 Feb 13;2014:bcr2013201916. doi: 10.1136/bcr-2013-201916. BMJ Case Rep. 2014. PMID: 24526195 Free PMC article.

2

Reversible pulmonary hypertension in neonatal Graves disease.

O'Donovan D, McMahon C, Costigan C, Oslizlok P, Duff D. O'Donovan D, et al. Ir Med J. 1997 Jun-Jul;90(4):147-8. Ir Med J. 1997. PMID: 9267095

3

[Graves' disease and pregnancy].

Altashina MV, Troshina EA, Sviridenko NY, Latkina NV. Altashina MV, et al. Klin Med (Mosk). 2012;90(10):71-3. Klin Med (Mosk). 2012. PMID: 23285769 Russian.

4

Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131)I treatment.

Nakchbandi IA, Wirth JA, Inzucchi SE. Nakchbandi IA, et al. Chest. 1999 Nov;116(5):1483-5. doi: 10.1378/chest.116.5.1483. Chest. 1999. PMID: 10559121 Free article.

5

Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.

Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K. Amino N, et al. J Clin Endocrinol Metab. 1981 Jul;53(1):113-6. doi: 10.1210/jcem-53-1-113. J Clin Endocrinol Metab. 1981. PMID: 6165731

6

Fetal therapy in fetal thyrotoxicosis: a case report.

Srisupundit K, Sirichotiyakul S, Tongprasert F, Luewan S, Tongsong T. Srisupundit K, et al. Fetal Diagn Ther. 2008;23(2):114-6. doi: 10.1159/000111589. Epub 2007 Nov 23. Fetal Diagn Ther. 2008. PMID: 18033967

7

Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.

Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. Tamaki H, et al. J Clin Endocrinol Metab. 1987 Aug;65(2):324-30. doi: 10.1210/jcem-65-2-324. J Clin Endocrinol Metab. 1987. PMID: 2885336

8

Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.

Fujishima A, Sato A, Miura H, Shimoda Y, Kameyama S, Ariake C, Adachi H, Fukuoka Y, Terada Y. Fujishima A, et al. BMC Pregnancy Childbirth. 2020 Jun 3;20(1):344. doi: 10.1186/s12884-020-03035-2. BMC Pregnancy Childbirth. 2020. PMID: 32493403 Free PMC article.

9

Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.

Finucane FM, O'Connell J, Kinsley BT. Finucane FM, et al. Ir J Med Sci. 2008 Mar;177(1):69-71. doi: 10.1007/s11845-007-0055-5. Epub 2007 Jul 5. Ir J Med Sci. 2008. PMID: 17611791

10

Neonatal thyrotoxicosis and conjugated hyperbilirubinemia.

Beroukhim RS, Moon TD, Felner EI. Beroukhim RS, et al. J Matern Fetal Neonatal Med. 2003 Jun;13(6):426-8. doi: 10.1080/jmf.13.6.426.428. J Matern Fetal Neonatal Med. 2003. PMID: 12962270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year